A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

NCT02385019 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease

Interventions

BIOLOGICAL: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease

Sponsor

Instituto de Medicina Molecular João Lobo Antunes

Collaborators

[object Object]
[object Object]
[object Object]